ARLINGTON, Va., Jan. 14, 2015 /PRNewswire/ -- BioInformatics LLC announced today the launch of its groundbreaking, dynamic-data presentation platform, Interactive Market Intelligence— the only cloud-based market research analytics tool for the life science tools industry.

Superior to traditional PDF and PowerPoint reports, Interactive Market Intelligence allows end-users to filter, create and export literally thousands of views of data — all easily obtainable from a set of core metrics that include market, brand, customer and workflow analytics in well-defined segments of the life science market.

The Market for Real-Time PCR is the first in a series of topics to be explored using the Interactive Market Intelligence platform. The primary research analysis is based on a survey of 900+ international scientists performing qPCR in their laboratories.

Key data findings from "The Market for Real-Time PCR":

• Global market for qPCR in 2015 is estimated to be $3.6B
• The average growth in qPCR throughput is expected to be at 9.8% in 2015
• 22% of respondents are highly likely to switch primary suppliers of qPCR products
• 50% of respondents use pre-designed primer/probe sets

A complete description of the Real Time PCR data available through Interactive Market Intelligence can be viewed in the report brochure.

See the Interactive Market Intelligence demo video

Upcoming market studies available on the Interactive Market Intelligence platform include:

The Market for Cell-Based Assays (to be available on 1/26/15)
The Market for Stem Cells (February 2015)

Contact us at info@gene2drug.com for more information and for a personal demonstration appointment.

ABOUT BIOINFORMATICS LLC

Now celebrating 20 years in business, BioInformatics LLC and its SDi division form the premier research and advisory firm serving the life science industry. By leveraging our expert network of more than 72,000 life scientists, the company has supported more than 500 companies in creating insights that lead to better business decisions. Offerings include assessing the size and attractiveness of scientific markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

www.gene2drug.com

For more information contact:

Zach French
Manager, Marketing & Business Development
BioInformatics LLC
2111 Wilson Blvd., Suite 250
Arlington, VA 22201
703.778.3080 x19 (phone)
z.french(at)gene2drug(dot)com
www.gene2drug.com

SOURCE BioInformatics LLC

Related Links

http://www.gene2drug.com